ZIMMER BIOMET HOLDINGS, INC. (ZBH)

↓ Download CSV

CIK 0001136869 · NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ZIMMER BIOMET HOLDINGS, INC. reported revenue of $8.23B, up 7.2% from the prior year. The company was profitable, with a net margin of 8.6%. It held $23.09B in total assets against $10.39B in total liabilities.

Key ratios (FY2025)

13.3%
Operating margin
8.6%
Net margin
5.5%
Return on equity
+7.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$8.23B$7.68B$7.39B$6.94B$6.83B$6.13B$7.98B$7.93B$7.80B$7.67B
Cost of Revenue$2.49B$2.19B$2.08B$2.02B$1.96B$1.82B$2.25B$2.27B$2.13B$2.38B
Operating Income$1.10B$1.29B$1.28B$696.30M$860.30M$83.10M$1.14B$33.80M$799.30M$821.10M
Net Income$705.10M$903.80M$1.02B$231.40M$401.60M-$138.90M$1.13B-$379.20M$1.81B$305.90M
EPS (Diluted)$3.55$4.43$4.88$1.10$1.91$-0.67$5.47$-1.86$8.90$1.51
Total Assets$23.09B$21.37B$21.50B$21.07B$23.46B$24.42B$24.64B$24.13B$26.01B$26.68B
Total Liabilities$10.39B$8.89B$9.01B$9.04B$10.79B$12.22B$12.25B$12.85B$14.28B$17.01B
Shareholders' Equity$12.71B$12.48B$12.49B$12.03B$12.67B$12.20B$12.39B$11.28B$11.74B$9.67B
Cash & Equivalents$591.90M$525.50M$415.80M$375.70M$378.10M$802.10M$617.90M$542.80M$524.40M$634.10M
Operating Cash Flow$1.70B$1.50B$1.58B$1.50B$1.20B$1.59B$1.75B$1.58B$1.63B
Capital Expenditures$224.50M$203.80M$291.10M$187.90M$143.60M$111.90M$207.10M$162.70M$156.00M$184.70M
Shares Outstanding198.70M203.90M209.70M210.30M210.40M207.00M206.70M203.50M203.70M202.40M
Dividends Per Share$0.96$0.96$0.96$0.96$0.96$0.96$0.96$0.96$0.96$0.96